GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Predilife SA (XPAR:ALPRE) » Definitions » EV-to-Revenue

Predilife (XPAR:ALPRE) EV-to-Revenue : 98.01 (As of May. 13, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Predilife EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Predilife's enterprise value is €29.60 Mil. Predilife's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €0.30 Mil. Therefore, Predilife's EV-to-Revenue for today is 98.01.

The historical rank and industry rank for Predilife's EV-to-Revenue or its related term are showing as below:

XPAR:ALPRE' s EV-to-Revenue Range Over the Past 10 Years
Min: 61.67   Med: 169.64   Max: 1121.76
Current: 98.02

During the past 7 years, the highest EV-to-Revenue of Predilife was 1121.76. The lowest was 61.67. And the median was 169.64.

XPAR:ALPRE's EV-to-Revenue is ranked worse than
95.09% of 224 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.24 vs XPAR:ALPRE: 98.02

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-13), Predilife's stock price is €7.00. Predilife's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.08. Therefore, Predilife's PS Ratio for today is 84.34.


Predilife EV-to-Revenue Historical Data

The historical data trend for Predilife's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predilife EV-to-Revenue Chart

Predilife Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-Revenue
Get a 7-Day Free Trial 357.76 978.95 85.30 193.84 79.05

Predilife Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 193.84 - 79.05 -

Competitive Comparison of Predilife's EV-to-Revenue

For the Diagnostics & Research subindustry, Predilife's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Predilife's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Predilife's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Predilife's EV-to-Revenue falls into.



Predilife EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Predilife's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=29.600/0.302
=98.01

Predilife's current Enterprise Value is €29.60 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Predilife's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €0.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Predilife  (XPAR:ALPRE) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Predilife's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=7.00/0.083
=84.34

Predilife's share price for today is €7.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was €0.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Predilife EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Predilife's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Predilife (XPAR:ALPRE) Business Description

Traded in Other Exchanges
N/A
Address
114 rue Edouard Vaillant Espace Maurice Tubiana, Villejuif, Paris, FRA, 94800
Predilife SA develops solutions of predictive medicine combining proven medical techniques (genetic tests, medical imaging) and mathematical models using a large number of statistical data that could allow each individual to define his risk profile for the occurrence of a large number of serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.

Predilife (XPAR:ALPRE) Headlines

No Headlines